Alimera Reports Results From the Six-Month Interim Readout of the Human PK Iluvien Study
Alimera Sciences, Inc., a privately held biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today reported the interim ...